GEHC GE HealthCare Technologies Inc

Price (delayed)

$73.69

Market cap

$33.28B

P/E Ratio

16.9

Dividend/share

$0.14

EPS

$4.36

Enterprise value

$41.27B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 64

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make ...

Highlights
The company's equity rose by 13% YoY and by 2.9% QoQ
GE HealthCare Technologies's revenue has increased by 7% YoY
GEHC's net income is down by 11% year-on-year but it is up by 3.9% since the previous quarter
The EPS has declined by 11% year-on-year but it has increased by 4.3% since the previous quarter
The gross margin has contracted by 5% YoY
GEHC's price to earnings (P/E) is 3.7% higher than its last 4 quarters average of 16.3

Key stats

What are the main financial stats of GEHC

GEHC stock price

How has the GE HealthCare Technologies stock price performed over time
Intraday
-0.14%
1 week
2.68%
1 month
19.51%
1 year
0.04%
YTD
-10.16%
QTD
15.12%

Financial performance

How have GE HealthCare Technologies's revenue and profit performed over time
Revenue
$21.27B
Gross profit
$8.41B
Operating income
$2.73B
Net income
$1.99B
Gross margin
39.5%
Net margin
9.3%
The net margin has declined by 17% year-on-year but it has increased by 2.2% since the previous quarter
GEHC's net income is down by 11% year-on-year but it is up by 3.9% since the previous quarter
GE HealthCare Technologies's revenue has increased by 7% YoY
GE HealthCare Technologies's operating margin has decreased by 7% YoY but it has increased by 2.4% QoQ

Price vs fundamentals

How does GEHC's price correlate with its fundamentals

Growth

What is GE HealthCare Technologies's growth rate over time

Valuation

What is GE HealthCare Technologies stock price valuation
P/E
16.9
P/B
3.05
P/S
1.57
EV/EBIT
13.66
EV/EBITDA
11.37
EV/Sales
1.94
The EPS has declined by 11% year-on-year but it has increased by 4.3% since the previous quarter
GEHC's price to earnings (P/E) is 3.7% higher than its last 4 quarters average of 16.3
The company's equity rose by 13% YoY and by 2.9% QoQ
The P/B is 4.7% lower than the last 4 quarters average of 3.2
GE HealthCare Technologies's revenue has increased by 7% YoY

Efficiency

How efficient is GE HealthCare Technologies business performance
The ROE has contracted by 25% YoY
GE HealthCare Technologies's return on invested capital has decreased by 18% YoY
GEHC's ROA is down by 18% YoY but it is up by 3.8% QoQ
The return on sales has declined by 11% year-on-year

Dividends

What is GEHC's dividend history
DPS
$0.14
Dividend yield
0.19%
Payout ratio
3.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did GE HealthCare Technologies financials performed over time
The total assets is 43% greater than the total liabilities
GEHC's current ratio is up by 9% year-on-year and by 3.3% since the previous quarter
The total assets is up by 4.9% year-on-year
The debt is 8% smaller than the equity
GEHC's debt to equity is down by 13% YoY and by 3.2% from the previous quarter
The company's equity rose by 13% YoY and by 2.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.